Predictors and Recurrence Patterns After Radical Surgery in Ampulla of Vater Cancer: Comparative Analysis Between Early and Late Recurrence

Overview

Journal Front Surg

Specialty General Surgery

Date 2022 Apr 4

PMID 35372475

Authors

Zheng-Yun Zhang

Da-Wei Liu

Di-Si Hao

Zun-Qiang Zhou

Affiliations

Soon will be listed here.

Abstract

Objective: Tumor recurrence remains the main dilemma after surgical treatment of ampulla of Vater carcinoma. This study was designed to identify the prognostic factors and evaluate the recurrence patterns of ampulla of Vater cancer.

Methods: A total of 286 patients who underwent surgical resection of ampulla of Vater cancer in two medical centers from January 2000 to October 2016 were collected. Data on clinicopathologic factors, survival rate, and recurrence patterns were retrospectively analyzed.

Results: A total of 158 patients (55.2%) survived without evidence of recurrence (non-recurrence), whereas 65 (22.7%) and 63 patients (22.1%) suffered from recurrence of the disease within 12 months (early recurrence) and after 12 months (late recurrence), respectively. Early-recurrence patients exhibited a more advanced disease (advanced tumor stage, lymph node involvement, pancreas invasion, and late TNM stage) than late-recurrence patients. The first or primary location of cancer recurrence in 33 patients (25.8%) was locoregional. Metastasis developed in the liver in 30 patients (23.4%), peritoneum in 13 patients (10.2%), lungs in 10 patients (7.8%), and para-aortic or superior mesenteric artery lymph node in 10 patients (7.8%). Multiple metastases were observed in 26 patients (20.3%).

Conclusion: The most common patterns of postoperative recurrence are locoregional and recurrent liver metastasis. The recurrence patterns with the worst prognosis are peritoneal and multiple metastases.

References

Adsay V, Ohike N, Tajiri T, Kim G, Krasinskas A, Balci S . Ampullary region carcinomas: definition and site specific classification with delineation of four clinicopathologically and prognostically distinct subsets in an analysis of 249 cases. Am J Surg Pathol. 2012; 36(11):1592-608. DOI: 10.1097/PAS.0b013e31826399d8. View

Woo S, Ryu J, Lee S, Yoo J, Park J, Kim Y . Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma. Ann Surg Oncol. 2007; 14(11):3195-201. DOI: 10.1245/s10434-007-9537-y. View

Shimizu Y, Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, Miyazaki M . The morbidity, mortality, and prognostic factors for ampullary carcinoma and distal cholangiocarcinoma. Hepatogastroenterology. 2008; 55(82-83):699-703. View

Mehta V, Fisher G, Ford J, Poen J, Vierra M, OBERHELMAN H . Adjuvant chemoradiotherapy for "unfavorable" carcinoma of the ampulla of Vater: preliminary report. Arch Surg. 2001; 136(1):65-9. DOI: 10.1001/archsurg.136.1.65. View

Beger H, Treitschke F, Gansauge F, Harada N, Hiki N, Mattfeldt T . Tumor of the ampulla of Vater: experience with local or radical resection in 171 consecutively treated patients. Arch Surg. 1999; 134(5):526-32. DOI: 10.1001/archsurg.134.5.526. View

Kayahara M, Ohta T . Gross appearance of the ampullary tumor predicts lymph node metastasis and outcome. Dig Surg. 2010; 27(2):127-31. DOI: 10.1159/000286839. View

Willett C, Czito B, Bendell J, Ryan D . Locally advanced pancreatic cancer. J Clin Oncol. 2005; 23(20):4538-44. DOI: 10.1200/JCO.2005.23.911. View

Klinkenbijl J, Jeekel J, Sahmoud T, van Pel R, Couvreur M, Veenhof C . Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg. 2000; 230(6):776-82; discussion 782-4. PMC: 1420941. DOI: 10.1097/00000658-199912000-00006. View

Showalter T, Zhan T, Anne P, Chervoneva I, Mitchell E, Yeo C . The influence of prognostic factors and adjuvant chemoradiation on survival after pancreaticoduodenectomy for ampullary carcinoma. J Gastrointest Surg. 2011; 15(8):1411-6. DOI: 10.1007/s11605-011-1518-6. View

10.

Hornick J, Johnston F, Simon P, Younkin M, Chamberlin M, Mitchem J . A single-institution review of 157 patients presenting with benign and malignant tumors of the ampulla of Vater: management and outcomes. Surgery. 2011; 150(2):169-76. PMC: 3155697. DOI: 10.1016/j.surg.2011.05.012. View

11.

Lee J, Lee K, Ryou H, Jun Y, Paik S, Park H . Significance analysis of histologic type and perineural invasion as prognostic factors after curative resection of ampulla of Vater carcinoma. Hepatogastroenterology. 2010; 57(99-100):646-52. View

12.

Michelassi F, Erroi F, Dawson P, Pietrabissa A, Noda S, Handcock M . Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct. Ann Surg. 1989; 210(4):544-54; discussion 554-6. PMC: 1357942. DOI: 10.1097/00000658-198910000-00015. View

13.

Albores-Saavedra J, Schwartz A, Batich K, Henson D . Cancers of the ampulla of vater: demographics, morphology, and survival based on 5,625 cases from the SEER program. J Surg Oncol. 2009; 100(7):598-605. DOI: 10.1002/jso.21374. View

14.

Akbulut S, Sahin T, Yilmaz S . Comment on pediatric living donor liver transplantation decade progress in Shanghai: Characteristics and risks factors of mortality. World J Gastroenterol. 2020; 26(30):4564-4566. PMC: 7438188. DOI: 10.3748/wjg.v26.i30.4564. View

15.

Chun Y, Pawlik T, Vauthey J . 8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers. Ann Surg Oncol. 2017; 25(4):845-847. DOI: 10.1245/s10434-017-6025-x. View

16.

Willett C . Intraoperative radiation therapy. Int J Clin Oncol. 2001; 6(5):209-14. DOI: 10.1007/pl00012107. View

17.

Kim W, Choi D, Choi S, Heo J, You D, Lee H . Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer. J Surg Oncol. 2011; 105(3):266-72. DOI: 10.1002/jso.22090. View

18.

Dolay K, Malya F, Akbulut S . Management of pancreatic head adenocarcinoma: From where to where?. World J Gastrointest Surg. 2019; 11(3):143-154. PMC: 6478601. DOI: 10.4240/wjgs.v11.i3.143. View

19.

Askew J, Connor S . Review of the investigation and surgical management of resectable ampullary adenocarcinoma. HPB (Oxford). 2013; 15(11):829-38. PMC: 4503279. DOI: 10.1111/hpb.12038. View

20.

Witzigmann H, Mobius C, Uhlmann D, Geissler F, Tannapfel A, Halm U . [Treatment concept of adenomas of Vater's ampulla]. Chirurg. 2000; 71(2):196-201. DOI: 10.1007/s001040050033. View